FIRST FINANCIAL CORP /IN/ - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST FINANCIAL CORP /IN/ ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$29,000
+81.2%
1350.0%0.02%
+66.7%
Q4 2020$16,000
+23.1%
1350.0%0.01%
+9.1%
Q3 2020$13,000
-23.5%
1350.0%0.01%
-21.4%
Q2 2020$17,000
+41.7%
1350.0%0.01%
+27.3%
Q1 2020$12,000
-14.3%
1350.0%0.01%
+10.0%
Q4 2019$14,000
-12.5%
1350.0%0.01%
-16.7%
Q3 2019$16,000
-30.4%
1350.0%0.01%
-36.8%
Q2 2019$23,0000.0%1350.0%0.02%
+11.8%
Q1 2019$23,000
+76.9%
1350.0%0.02%
+70.0%
Q4 2018$13,000
-43.5%
1350.0%0.01%
-33.3%
Q3 2018$23,000
+21.1%
1350.0%0.02%
+15.4%
Q2 2018$19,000
+26.7%
1350.0%0.01%
+18.2%
Q1 2018$15,000
-16.7%
1350.0%0.01%
-8.3%
Q4 2017$18,000
+28.6%
1350.0%0.01%
+33.3%
Q3 2017$14,0000.0%1350.0%0.01%0.0%
Q2 2017$14,000
-12.5%
1350.0%0.01%
-10.0%
Q1 2017$16,000
+6.7%
1350.0%0.01%
+11.1%
Q4 2016$15,000
-16.7%
1350.0%0.01%
-18.2%
Q3 2016$18,000
+50.0%
1350.0%0.01%
+57.1%
Q2 2016$12,000
+20.0%
1350.0%0.01%
+40.0%
Q1 2016$10,000
+11.1%
1350.0%0.01%0.0%
Q4 2015$9,000
-25.0%
1350.0%0.01%
-28.6%
Q3 2015$12,000
-29.4%
1350.0%0.01%
-22.2%
Q2 2015$17,000
+41.7%
1350.0%0.01%
+50.0%
Q1 2015$12,000
+33.3%
1350.0%0.01%
+50.0%
Q4 2014$9,000
-18.2%
1350.0%0.00%
-20.0%
Q3 2014$11,000
-21.4%
1350.0%0.01%
-28.6%
Q2 2014$14,0001350.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders